Helixmith Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Ji-Wook Jeong

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	sin datos

Actualizaciones recientes de la dirección

Recent updates

Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Feb 19

CEO

Ji-Wook Jeong

less than a year

Permanencia

Ji-Wook Jeong is CEO & President of Helixmith Co. Ltd from 2024.

Helixmith Dirección

Dirección controles de criterios 0/4

Información clave

Actualizaciones recientes de la dirección

No independent directors

No independent directors

Recent updates

Helixmith Co., Ltd announced that it has received KRW 3.37919826 billion in funding

Helixmith Co., Ltd announced that it expects to receive KRW 3.37919826 billion in funding

New minor risk - Share price stability

Helixmith Co., Ltd announced that it expects to receive KRW 9.999993078 billion in funding from CANARIABIO M Inc.

Price target decreased to ₩19,900

No independent directors

Helixmith Co., Ltd(KOSDAQ:A084990) dropped from FTSE All-World Index (USD)

Helixmith Announces Topline Results from Phase 2A Study of Engensis for Treatment of ALS (Amyotrophic Lateral Sclerosis)

Helixmith Announces Topline Results from Double-Blind Placebo Controlled Multicenter Study for TADIOS Involving 100 Subjects Infected with COVID-19

First quarter 2022 earnings released: ₩335 loss per share (vs ₩92.65 profit in 1Q 2021)

Price target increased to ₩29,182

Price target decreased to ₩26,529

No independent directors

Price target decreased to ₩26,529

Helixmith Announces 50% Enrollment in Clinical Trial for COVID-19, Involving TADIOS

Price target decreased to ₩33,000

New 90-day low: ₩24,550

Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Wacker Chemie AG (XTRA:WCH) entered into an agreement to acquire Genopis Inc. from Medivate Partners LLC and Helixmith Co., Ltd (KOSDAQ:A084990) for $39 million.

Helixmith Co., Ltd announced that it has received KRW 20 billion in funding

Helixmith Co., Ltd announced that it expects to receive KRW 20 billion in funding

Helixmith Co., Ltd has completed a Follow-on Equity Offering in the amount of KRW 161.25 billion.

New 90-day low: ₩30,750

Helixmith to Be Deleted from Other OTC

New 90-day low: ₩41,800

New 90-day low - ₩52,000

New 90-day low - ₩56,500

CEO

Permanencia